FDA approves J&J's autoimmune drug Stelara for Crohn's disease

(Reuters) - Johnson & Johnson said on Monday that the U.S. Food and Drug Administration approved the company's blockbuster psoriasis drug, Stelara, for use in adults with Crohn's disease.